Alendronat til forebyggelse og behandling af postmenopausal osteoporose

Keyphrases

• Secondary Prevention 100%
• Primary Prevention 100%
• Osteoporotic Fractures 100%
• Alendronate 100%
• Postmenopausal Women 100%
• Clinically Significant 42%
• Vertebral Fracture 28%
• Nonvertebral Fracture 28%
• Placebo 14%
• Wrist 14%
• Randomized Controlled Trial 14%
• Risk Reduction 14%
• Meta-analysis 14%
• Embase 14%
• MEDLINE 14%
• Allocation Concealment 14%
• Fracture Risk 14%
• Bisphosphonates 14%
• Relative Change 14%
• Relative Risk 14%
• Osteoporosis 14%
• Hip Fracture 14%
• Bone Resorption 14%
• Fracture Incidence 14%
• Vitamin D 14%
• Search Strategy 14%
• Selection Criteria 14%
• Bone Mass 14%
• Drug Class 14%
• Wrist Fracture 14%
• Postmenopausal Osteoporosis 14%
• Fracture Outcomes 14%
• Osteoclast 14%

Medicine and Dentistry

• Secondary Prevention 100%
• Postmenopause 100%
• Primary Prevention 100%
• Fragility Fracture 100%
• Alendronic Acid 100%
• Spine Fracture 57%
• Hip Fracture 28%
• Isotopes of Calcium 14%
• Meta-Analysis 14%
• Placebo 14%
• Randomized Controlled Trial 14%
• Risk Reduction 14%
• Vitamin D 14%
• Osteoporosis 14%
• Osteolysis 14%
• Deterioration 14%
• Bisphosphonate 14%
• Bone Mass 14%
• Postmenopause Osteoporosis 14%
• Osteoclast 14%
• Wrist Fracture 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Spine Fracture 100%
• Fragility Fracture 100%
• Alendronic Acid 100%
• Hip Fracture 50%
• Placebo 25%
• Randomized Controlled Trial 25%
• Bisphosphonic Acid Derivative 25%
• Vitamin D 25%
• Deterioration 25%
• Postmenopause Osteoporosis 25%